{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:59:34Z","timestamp":1790873974809,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04272-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:21:49Z","timestamp":1751368909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Infections and mortality in ICU patients undergoing continuous renal replacement therapy: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Danica","family":"Quickfall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"La","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Gunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay L.","family":"Koyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"4272_CR1","doi-asserted-by":"publisher","first-page":"k4891","DOI":"10.1136\/bmj.k4891","volume":"364","author":"JT Poston","year":"2019","unstructured":"Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ. 2019;364:k4891.","journal-title":"BMJ"},{"issue":"3","key":"4272_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11255-020-02601-z","volume":"53","author":"JC Badel","year":"2021","unstructured":"Badel JC, Garcia LA, Soto-Doria MJ, Musso CG. Dialysis prescription in acute kidney injury: when and how much? Int Urol Nephrol. 2021;53(3):489\u201396.","journal-title":"Int Urol Nephrol"},{"key":"4272_CR3","doi-asserted-by":"crossref","unstructured":"Pistolesi V, Morabito S, Di Mario F, Regolisti G, Cantarelli C, Fiaccadori E. A guide to understanding antimicrobial drug dosing in critically ill patients on renal replacement therapy. Antimicrob Agents Chemother 2019;63(8).","DOI":"10.1128\/AAC.00583-19"},{"issue":"6","key":"4272_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1159\/000529694","volume":"52","author":"T Charoensareerat","year":"2023","unstructured":"Charoensareerat T, Chaijamorn W, Kerdnimith P, Kosumwisaisakul N, Teeranaew P, Rungkitwattanakul D, Boonpeng A, Srisawat N, Pattharachayakul S. Optimal meropenem dosing regimens in patients undergoing continuous renal replacement therapy: systematic review and Monte Carlo simulations. Blood Purif. 2023;52(6):503\u201315.","journal-title":"Blood Purif"},{"issue":"7","key":"4272_CR5","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.ekir.2021.04.035","volume":"6","author":"N Tantranont","year":"2021","unstructured":"Tantranont N, Luque Y, Hsiao M, Haute C, Gaber L, Barrios R, Adrogue HE, Niasse A, Truong LD. Vancomycin-Associated tubular casts and Vancomycin nephrotoxicity. Kidney Int Rep. 2021;6(7):1912\u201322.","journal-title":"Kidney Int Rep"},{"issue":"2","key":"4272_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000487149","volume":"139","author":"VJCQ Obadan Ndidiamaka","year":"2018","unstructured":"Obadan Ndidiamaka VJCQ, Kaushal O, Alzubaidi A, Bhasin M, Sachdev Sachin B, Karakala H, Arthur John N, Nesbit Ross M. Phadke Gautam M: Vancomycin-Associated acute kidney injury with a steep rise in serum creatinine. Nephron. 2018;139(2):131\u201342.","journal-title":"Nephron"},{"issue":"2","key":"4272_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5492\/wjccm.v12.i2.71","volume":"12","author":"Y Mehta","year":"2023","unstructured":"Mehta Y, Paul R, Ansari AS, Banerjee T, Gunaydin S, Nassiri AA, Pappalardo F, Premu\u017ei\u0107 V, Sathe P, Singh V, et al. Extracorporeal blood purification strategies in sepsis and septic shock: an insight into recent advancements. World J Crit Care Med. 2023;12(2):71\u201388.","journal-title":"World J Crit Care Med"},{"issue":"5","key":"4272_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5301\/ijao.5000587","volume":"40","author":"MJ Santiago","year":"2017","unstructured":"Santiago MJ, L\u00f3pez-Herce J, Vierge E, Castillo A, Bustinza A, Bell\u00f3n JM, S\u00e1nchez A, Fern\u00e1ndez S. Infection in critically ill pediatric patients on continuous renal replacement therapy. Int J Artif Organs. 2017;40(5):224\u20139.","journal-title":"Int J Artif Organs"},{"key":"4272_CR9","doi-asserted-by":"crossref","unstructured":"Gautam SC, Lim J, Jaar BG. Complications associated with continuous RRT. Kidney360. 2022;3(11):1980\u20131990.","DOI":"10.34067\/KID.0000792022"},{"issue":"4","key":"4272_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1053\/j.ajkd.2016.03.427","volume":"68","author":"E Macedo","year":"2016","unstructured":"Macedo E, Mehta RL. Continuous Dialysis therapies: core curriculum 2016. Am J Kidney Dis. 2016;68(4):645\u201357.","journal-title":"Am J Kidney Dis"},{"key":"4272_CR11","doi-asserted-by":"crossref","unstructured":"Ki KK, Heinsar S, Langguth D, Fraser JF. Extracorporeal circulation-related immune response. In: Management of Dysregulated Immune Response in the Critically Ill. edn. Edited by Molnar Z, Ostermann M, Shankar-Hari M. Cham: Springer International Publishing. 2023;85\u2013112.","DOI":"10.1007\/978-3-031-17572-5_5"},{"issue":"1","key":"4272_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13613-016-0199-4","volume":"6","author":"G Zilahi","year":"2016","unstructured":"Zilahi G, Artigas A, Martin-Loeches I. What\u2019s new in multidrug-resistant pathogens in the ICU? Ann Intensive Care. 2016;6(1):96.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"4272_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1060028019865873","volume":"54","author":"BM Hoff","year":"2020","unstructured":"Hoff BM, Maker JH, Dager WE, Heintz BH. Antibiotic dosing for critically ill adult patients receiving intermittent hemodialysis, prolonged intermittent renal replacement therapy, and continuous renal replacement therapy: an update. Ann Pharmacother. 2020;54(1):43\u201355.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"4272_CR14","doi-asserted-by":"publisher","first-page":"107311","DOI":"10.1016\/j.ijantimicag.2024.107311","volume":"64","author":"ML Cree","year":"2024","unstructured":"Cree ML, Abdul-Aziz MH, Schlapbach LJ, Roberts JA, Parker SL. The impact of extracorporeal support on antimicrobial pharmacokinetics in critically ill neonatal and paediatric patients: A systematic review. Int J Antimicrob Agents. 2024;64(4):107311.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"4272_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/jac\/dky477","volume":"74","author":"AJ Denisuik","year":"2018","unstructured":"Denisuik AJ, Garbutt LA, Golden AR, Adam HJ, Baxter M, Nichol KA, Lagac\u00e9-Wiens P, Walkty AJ, Karlowsky JA, Hoban DJ, et al. Antimicrobial-resistant pathogens in Canadian icus: results of the CANWARD 2007 to 2016 study. J Antimicrob Chemother. 2018;74(3):645\u201353.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"4272_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MCC.0000000000000124","volume":"20","author":"I Mart\u00edn-Loeches","year":"2014","unstructured":"Mart\u00edn-Loeches I, Diaz E, Vall\u00e9s J. Risks for multidrug-resistant pathogens in the ICU. Curr Opin Crit Care. 2014;20(5):516\u201324.","journal-title":"Curr Opin Crit Care"},{"key":"4272_CR17","doi-asserted-by":"publisher","unstructured":"Fiorentino M, La Fergola F, Carparelli S, Gesualdo L. Mortality and kidney function recovery in patients with sepsis-associated AKI vs. nonseptic AKI treated with continuous kidney replacement therapy: TH-PO063. J Am Soc Nephrol. 2024;35(10S). https:\/\/doi.org\/10.1681\/ASN.2024hwsyw1606q.","DOI":"10.1681\/ASN.2024hwsyw1606q"},{"key":"4272_CR18","doi-asserted-by":"publisher","first-page":"e945815","DOI":"10.12659\/AOT.945815","volume":"29","author":"J Stru\u017cyna","year":"2024","unstructured":"Stru\u017cyna J, Tomaka P, Surowiecka A, Korzeniowski T, Wilhelm G, \u0141\u0105czyk M, M\u0105dry R, Bugaj-Tobiasz M, Antonov S, Drozd \u0141, et al. Ten-Year retrospective analysis of continuous renal replacement therapy in burn patients: impact on survival and timing of initiation. Ann Transpl. 2024;29:e945815.","journal-title":"Ann Transpl"},{"issue":"3","key":"4272_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJMoa2000741","volume":"383","author":"SM Bagshaw","year":"2020","unstructured":"Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D, Du B, Gallagher MP, Gaudry S, Hoste EA, et al. Timing of initiation of Renal-Replacement therapy in acute kidney injury. N Engl J Med. 2020;383(3):240\u201351.","journal-title":"N Engl J Med"},{"issue":"2","key":"4272_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1603017","volume":"375","author":"S Gaudry","year":"2016","unstructured":"Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D, et al. Initiation strategies for Renal-Replacement therapy in the intensive care unit. N Engl J Med. 2016;375(2):122\u201333.","journal-title":"N Engl J Med"},{"key":"4272_CR21","doi-asserted-by":"publisher","first-page":"205435811985293","DOI":"10.1177\/2054358119852937","volume":"6","author":"STandard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury","year":"2019","unstructured":"STandard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury. Study protocol for a Multi-National, Multi-Center, randomized controlled trial. Can J Kidney Health Dis. 2019;6:2054358119852937.","journal-title":"Can J Kidney Health Dis"},{"key":"4272_CR22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3389\/fphar.2020.00786","volume":"11","author":"C Chen","year":"2020","unstructured":"Chen C, et al. Recommendation of antimicrobial dosing optimization during continuous renal replacement therapy. Front Pharmacol. 2020;11:786. https:\/\/doi.org\/10.3389\/fphar.2020.00786.","journal-title":"Front Pharmacol"},{"key":"4272_CR23","doi-asserted-by":"publisher","first-page":"154059","DOI":"10.1016\/j.jcrc.2023.154059","volume":"73","author":"L Hu","year":"2023","unstructured":"Hu L, et al. Risk factors for clinical treatment failure and death in patients with Multidrug-Resistant infections. J Crit Care. 2023;73:154059. https:\/\/doi.org\/10.1016\/j.jcrc.2023.154059.","journal-title":"J Crit Care"},{"issue":"2","key":"4272_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00134-022-06944-2","volume":"49","author":"A Tabah","year":"2023","unstructured":"Tabah A, Buetti N, Staiquly Q, Ruckly S, Akova M, Aslan AT, Leone M, Conway Morris A, Bassetti M, Arvaniti K, et al. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med. 2023;49(2):178\u201390.","journal-title":"Intensive Care Med"},{"key":"4272_CR25","doi-asserted-by":"crossref","unstructured":"Coloretti I, Girardis M. Critically Ill Surgical Patients in the Intensive Care Unit. In: Infections in Surgery: Prevention and Management. edn. Edited by Bartoli S, Cortese F, Sartelli M, Sganga G. Cham: Springer Nature Switzerland. 2025;143\u2013152.","DOI":"10.1007\/978-3-031-60462-1_17"},{"issue":"1","key":"4272_CR26","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1186\/s12879-022-07837-x","volume":"22","author":"CH Park","year":"2022","unstructured":"Park CH, Lee JW, Lee HJ, Oh DK, Park MH, Lim C-M, Hong S-K, Lim C-M, Hong S-B, Oh DK, et al. Clinical outcomes and prognostic factors of patients with sepsis caused by intra-abdominal infection in the intensive care unit: a post-hoc analysis of a prospective cohort study in Korea. BMC Infect Dis. 2022;22(1):953.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"4272_CR27","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1164\/rccm.201310-1875OC","volume":"189","author":"A Leligdowicz","year":"2014","unstructured":"Leligdowicz A, Dodek PM, Norena M, Wong H, Kumar A, Kumar A. Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med. 2014;189(10):1204\u201313.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"4272_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jiph.2017.01.013","volume":"10","author":"R Moghnieh","year":"2017","unstructured":"Moghnieh R, Alothman AF, Althaqafi AO, Matar MJ, Alenazi TH, Farahat F, Corman SL, Solem CT, Raghubir N, Macahilig C, et al. Epidemiology and outcome of invasive fungal infections and methicillin-resistant Staphylococcus aureus (MRSA) pneumonia and complicated skin and soft tissue infections (cSSTI) in Lebanon and Saudi Arabia. J Infect Public Health. 2017;10(6):849\u201354.","journal-title":"J Infect Public Health"},{"issue":"10","key":"4272_CR29","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jiac.2023.06.008","volume":"29","author":"JN Hu","year":"2023","unstructured":"Hu JN, Hu SQ, Li ZL, Bao C, Liu Q, Liu C, Xu SY. Risk factors of multidrug-resistant bacteria infection in patients with ventilator-associated pneumonia: a systematic review and meta-analysis. J Infect Chemother. 2023;29(10):942\u20137.","journal-title":"J Infect Chemother"},{"issue":"5, Supplement 1","key":"4272_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.amjsurg.2003.10.006","volume":"186","author":"Wilson","year":"2003","unstructured":"Wilson MA. Skin and soft-tissue infections: impact of resistant gram-positive bacteria. Am J Surg. 2003;186(5, Supplement 1):35\u201341.","journal-title":"Am J Surg"},{"issue":"7","key":"4272_CR31","first-page":"997","volume":"37","author":"LJ Eron","year":"2003","unstructured":"Eron LJ, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. Clin Infect Dis. 2003;37(7):997\u20131003.","journal-title":"Clin Infect Dis"},{"key":"4272_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijid.2014.12.022","volume":"31","author":"P Cornejo-Ju\u00e1rez","year":"2015","unstructured":"Cornejo-Ju\u00e1rez P, Vilar-Compte D, P\u00e9rez-Jim\u00e9nez C, \u00d1amendys-Silva SA, Sandoval-Hern\u00e1ndez S, Volkow-Fern\u00e1ndez P. The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int J Infect Dis. 2015;31:31\u20134.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"4272_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jmii.2015.07.001","volume":"50","author":"K-Y Lin","year":"2017","unstructured":"Lin K-Y, Cheng A, Chang Y-C, Hung M-C, Wang J-T, Sheng W-H, Hseuh P-R, Chen Y-C, Chang S-C. Central line-associated bloodstream infections among critically-ill patients in the era of bundle care. J Microbiol Immunol Infect. 2017;50(3):339\u201348.","journal-title":"J Microbiol Immunol Infect"},{"key":"4272_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13756-023-01349-8","volume":"13","author":"JP Mouton","year":"2024","unstructured":"Mouton JP, Perovic O, Orth H, Duse A, van Vuuren C, Richards G, et al. Risk factors for colonization with multidrug-resistant bacteria in patients admitted to a tertiary care hospital in South Africa. Antimicrob Resist Infect Control. 2024;13:9. https:\/\/doi.org\/10.1186\/s13756-023-01349-8.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"2","key":"4272_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3201\/eid0702.010226","volume":"7","author":"RM Donlan","year":"2001","unstructured":"Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001;7(2):277\u201381. https:\/\/doi.org\/10.3201\/eid0702.010226.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"4272_CR36","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1093\/ndt\/14.6.1494","volume":"14","author":"L Kairaitis","year":"1999","unstructured":"Kairaitis L, Gottlieb T. Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transpl. 1999;14(6):1494\u20138. https:\/\/doi.org\/10.1093\/ndt\/14.6.1494.","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"4272_CR37","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s10096-012-1568-z","volume":"31","author":"PY Delannoy","year":"2012","unstructured":"Delannoy PY, Boussekey N, Devos P, Alfandari S, Turbelin C, Chiche A, Meybeck A, Georges H, Leroy O. Impact of combination therapy with aminoglycosides on the outcome of ICU-acquired bacteraemias. Eur J Clin Microbiol Infect Dis. 2012;31(9):2293\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"4272_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.medin.2015.07.009","volume":"39","author":"MO Cotta","year":"2015","unstructured":"Cotta MO, Roberts JA, Lipman J. Antibiotic dose optimization in critically ill patients. Med Intensiva. 2015;39(9):563\u201372.","journal-title":"Med Intensiva"},{"issue":"1","key":"4272_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13054-018-2155-1","volume":"22","author":"RP Veiga","year":"2018","unstructured":"Veiga RP, Paiva JA. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients. Crit Care. 2018;22(1):233.","journal-title":"Crit Care"},{"issue":"5","key":"4272_CR40","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1186\/cc10441","volume":"15","author":"J Gon\u00e7alves-Pereira","year":"2011","unstructured":"Gon\u00e7alves-Pereira J, P\u00f3voa P. Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of \u03b2-lactams. Crit Care. 2011;15(5):R206.","journal-title":"Crit Care"},{"key":"4272_CR41","doi-asserted-by":"publisher","first-page":"212527","DOI":"10.7573\/dic.212527","volume":"7","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context. 2018;7:212527.","journal-title":"Drugs Context"},{"issue":"4","key":"4272_CR42","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1586\/14787210.4.4.639","volume":"4","author":"P Grossi","year":"2006","unstructured":"Grossi P, Gasperina DD. Treatment of Pseudomonas aeruginosa infection in critically ill patients. Expert Rev Anti-infective Therapy. 2006;4(4):639\u201362.","journal-title":"Expert Rev Anti-infective Therapy"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04272-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04272-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04272-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:21:53Z","timestamp":1751368913000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04272-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4272"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04272-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board at the University of Chicago and conducted in accordance with institutional and national research ethics guidelines. As a retrospective chart review using anonymized data, the requirement for informed consent was waived by the IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"321"}}